SMS LIFESCIENCES INDIA
Quarterly Results Analysis [Mar2025]
SMS LIFESCIENCES INDIA Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹89 Cr | ₹85 Cr | ₹78 Cr | ₹93 Cr | ₹90 Cr | ₹72 Cr | ₹69 Cr | ₹75 Cr |
Expenses | ₹82 Cr | ₹72 Cr | ₹70 Cr | ₹76 Cr | ₹79 Cr | ₹63 Cr | ₹61 Cr | ₹72 Cr |
Operating Income | ₹7 Cr | ₹13 Cr | ₹9 Cr | ₹16 Cr | ₹11 Cr | ₹9 Cr | ₹8 Cr | ₹3 Cr |
Other Income | ₹2 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr |
Interest | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹4 Cr | ₹7 Cr | ₹5 Cr | ₹11 Cr | ₹7 Cr | ₹4 Cr | ₹2 Cr | ₹-3 Cr |
Profit After Tax | ₹3 Cr | ₹5 Cr | ₹3 Cr | ₹7 Cr | ₹6 Cr | ₹4 Cr | ₹0 Cr | ₹-4 Cr |
EPS | ₹9.83 | ₹18.08 | ₹15.46 | ₹23.15 | ₹19.53 | ₹14.24 | ₹2.25 | ₹-5.94 |
Industry Peers & Returns | 1W | 1M | 1Y |
SMS LIFESCIENCES INDIA | -0.8% | -1.9% | 48% |
SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -1.3% | 6.6% |
DIVIS LABORATORIES | 1.8% | 4.8% | 49.8% |
CIPLA | -1.1% | -1.3% | -1.4% |
TORRENT PHARMACEUTICALS | 0.6% | 4.2% | 15.1% |
DR REDDYS LABORATORIES | -1.8% | -6% | -1.6% |
MANKIND PHARMA | 6.9% | 6.2% | 13.7% |
ZYDUS LIFESCIENCES | -2.1% | -0.3% | -15.4% |
LUPIN | -2.2% | -4.7% | 8.6% |
SMS LIFESCIENCES INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 5.33 % |
Y-o-Y | -0.98 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹89 Cr | 5.33 | |
Dec2024 | ₹85 Cr | 7.82 | |
Sep2024 | ₹78 Cr | -15.22 | |
Jun2024 | ₹93 Cr | 2.84 | |
Mar2024 | ₹90 Cr | 24.90 | |
Dec2023 | ₹72 Cr | 4.03 | |
Sep2023 | ₹69 Cr | -7.22 | |
Jun2023 | ₹75 Cr | - |
SMS LIFESCIENCES INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -41.82 % |
Y-o-Y | -34.67 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹7 Cr | -41.82 | |
Dec2024 | ₹13 Cr | 48.94 | |
Sep2024 | ₹9 Cr | -47.41 | |
Jun2024 | ₹16 Cr | 43.35 | |
Mar2024 | ₹11 Cr | 22.24 | |
Dec2023 | ₹9 Cr | 18.17 | |
Sep2023 | ₹8 Cr | 210.71 | |
Jun2023 | ₹3 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -44.76 % |
Y-o-Y | -33.99 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 8.33% | -44.76 | |
Dec2024 | 15.08% | 38.22 | |
Sep2024 | 10.91% | -38.01 | |
Jun2024 | 17.6% | 39.46 | |
Mar2024 | 12.62% | -2.17 | |
Dec2023 | 12.9% | 13.66 | |
Sep2023 | 11.35% | 234.81 | |
Jun2023 | 3.39% | - |
SMS LIFESCIENCES INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -28.23 % |
Y-o-Y | -46.22 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹3 Cr | -28.23 | |
Dec2024 | ₹5 Cr | 47.11 | |
Sep2024 | ₹3 Cr | -53.50 | |
Jun2024 | ₹7 Cr | 9.56 | |
Mar2024 | ₹6 Cr | 57.03 | |
Dec2023 | ₹4 Cr | Positive | |
Sep2023 | ₹0 Cr | Negative | |
Jun2023 | ₹-4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -31.88 % |
Y-o-Y | -45.69 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 3.91 % | -31.88 | |
Dec2024 | 5.74 % | 36.67 | |
Sep2024 | 4.2 % | -45.24 | |
Jun2024 | 7.67 % | 6.53 | |
Mar2024 | 7.2 % | 25.87 | |
Dec2023 | 5.72 % | Positive | |
Sep2023 | -0.64 % | Negative | |
Jun2023 | -5.13 % | - |
SMS LIFESCIENCES INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -45.63 % |
Y-o-Y | -49.67 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹9.83 | -45.63 | |
Dec2024 | ₹18.08 | 16.95 | |
Sep2024 | ₹15.46 | -33.22 | |
Jun2024 | ₹23.15 | 18.54 | |
Mar2024 | ₹19.53 | 37.15 | |
Dec2023 | ₹14.24 | 532.89 | |
Sep2023 | ₹2.25 | Positive | |
Jun2023 | ₹-5.94 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD